Impact of trial eligibility criteria on enrollment to KRAS(G12C) inhibitor trials in patients with non-small cell lung cancer Meeting Abstract
| Authors: | May, M. S.; Wooster, M.; May, B.; Shu, C. A.; Henick, B. S.; Stoopler, M.; Smith-Marrone, S.; Saqi, A.; Mansukhani, M. M.; Riely, G. J.; Hershman, D. L.; Herzberg, B. |
| Abstract Title: | Impact of trial eligibility criteria on enrollment to KRAS(G12C) inhibitor trials in patients with non-small cell lung cancer |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402487 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.11012 |
| Notes: | Meeting Abstract: 11012 -- Source: Wos |
